Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 4, 2013, Pages 386-391

  Klein, Christopher J ^a   Wu, Yanhong ^a   Kilfoyle, Dean H ^b   Sandroni, Paola ^a   Davis, Mark D ^a   Gavrilova, Ralitza H ^a   Low, Phillip A ^a   Dyck, Peter J ^a  

^a MAYO CLINIC   (United States)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; SODIUM CHANNEL NAV1.7;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; COHORT ANALYSIS; CONGENITAL ANALGESIA; CONTROLLED STUDY; DNA SEQUENCE; ERYTHROMELALGIA; EXON; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INFANT; MALE; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FIBER NEUROPATHY; SPLICING DEFECT;

EID: 84875209114     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303719     Document Type: Article

References (38)

1. Davis MD, Weenig RH, Genebriera J, et al. Histopathologic findings in primary erythromelalgia are nonspecific: special studies show a decrease in small nerve fiber density. J Am Acad Dermatol 2006;55:519-22. (Pubitemid 44189596)
2. Davis MD, Sandroni P, Rooke TW, et al. Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia. Arch Dermatol 2003;139:1337-43. (Pubitemid 37248284)
3. Sandroni P, Davis MD, Harper CM, et al. Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis. J Clin Neuromuscul Dis 1999;1:57-63.
4. Klein CJ. HSAN's clinical features, pathologic classification, and molecular genetics. In: Dyck PJ, Thomas PK eds. Peripheral neuropathy. Philadelphia, Saunders, 2005:1809-44.
5. Yang Y, Wang Y, Li S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 2004;41:171-4. (Pubitemid 38333793)
6. Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006;444:894-8. (Pubitemid 46024997)
7. Catterall WA, Goldin AL, Waxman SG, International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005;57:397-409. (Pubitemid 43036431)
8. Rush AM, Cummins TR. Painful research: identification of a small-molecule inhibitor that selectively targets Nav1.8 sodium channels. Mol Interv 2007;7:192-5, 80. (Pubitemid 47437264)
9. Waxman SG. Neuroscience: channelopathies have many faces. Nature 2011;472:173-4.
10. Fertleman CR, Ferrie CD, Aicardi J, et al. Paroxysmal extreme pain disorder (previously familial rectal pain syndrome). Neurology 2007;69:586-95. (Pubitemid 47357266)
11. Singh NA, Pappas C, Dahle EJ, et al. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet 2009;5:e1000649.
12. Han C, Hoeijmakers JG, Ahn HS, et al. Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability. Neurology 2012;78:1635-43.
13. Faber CG, Hoeijmakers JG, Ahn HS, et al. Gain of function Na(V) 1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012;71:26-39.
14. Goldberg YP, MacFarlane J, MacDonald ML, et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 2007;71:311-19. (Pubitemid 46690905)
15. Weiss J, Pyrski M, Jacobi E, et al. Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature 2011;472:186-90.
16. Human Genome Mutation Database HGMD. SCN9A. 2012. http://www.biobase.com/ hgmd [cited (accessed Jun 2012)].
17. Dyck PJ, Litchy WJ, Lehman KA, et al. Variables influencing neuropathic endpoints: the rochester diabetic neuropathy study of healthy subjects. Neurology 1995;45:1115-21.
18. Klein CJ, Sinnreich M, Dyck PJ. Indifference rather than insensitivity to pain. Ann Neurol 2003;53:417-18; author reply 8-9.
19. Dyck PJ, O'Brien PC, Johnson DM, et al. Quantitative sensation testing. In: Dyck PJ ed. Peripheral neuropathy. Philadelphia: Elsevier, 2005:1063-93.
20. Low PA, Caskey PE, Tuck RR, et al. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983;14:573-80. (Pubitemid 14239727)
21. Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 1989;64:617-28. (Pubitemid 19197633)
22. Dyck PJ, Mellinger JF, Reagan TJ, et al. Not 'indifference to pain' but varieties of hereditary sensory and autonomic neuropathy. Brain 1983;106:373-90. (Pubitemid 13098515)
23. Kurban M, Wajid M, Shimomura Y, et al. A nonsense mutation in the SCN9A gene in congenital insensitivity to pain. Dermatology 2010;221:179-83.
24. Han C, Dib-Hajj SD, Lin Z, et al. Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation. Brain 2009;132(Pt 7):1711-22.
25. Drenth JP, te Morsche RH, Guillet G, et al. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol 2005;124:1333-8. (Pubitemid 40847424)
26. Samuels ME, te Morsche RH, Lynch ME, et al. Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgia. Mol Pain 2008; 4:21.
27. Reimann F, Cox JJ, Belfer I, et al. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci USA 2010;107:5148-53.
28. Raymond CK, Castle J, Garrett-Engele P, et al. Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J Biol Chem 2004;279:46234-41. (Pubitemid 39491618)
29. Server EV. NHLBI Exome Sequencing Project (ESP). http://evs.gs. washington.edu/EVS/ (accessed 24 May 2012).
30. Vargas-Alarcon G, Alvarez-Leon E, Fragoso JM, et al. A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet Disord 2012;13:23.
31. Ames A 3rd. CNS energy metabolism as related to function. Brain Res Brain Res Rev [Review] 2000;34:42-68.
32. Persson AK, Black JA, Gasser A, et al. Sodium-calcium exchanger and multiple sodium channel isoforms in intra-epidermal nerve terminals. Molecular Pain [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]. 2010;6:84.
33. Chung MK, Jung SJ, Oh SB. Role of TRP channels in pain sensation. Adv Exp Med Biol 2011;704:615-36.
34. Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003;299:1240-3. (Pubitemid 36237467)
35. Tegeder I, Costigan M, Griffin RS, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006;12:1269-77. (Pubitemid 44706929)
36. Paticoff J, Valovska A, Nedeljkovic SS, et al. Defining a treatable cause of erythromelalgia: acute adolescent autoimmune small-fiber axonopathy. Anesth Analg 2007;104:438-41. (Pubitemid 46146756)
37. Klein CJ, Lennon VA, Aston PA, et al. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology 2012;79:1136-44.
38. Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve 2006;34:57-61.